Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Segment Information (Tables)

v3.19.3
Note 13 - Segment Information (Tables)
3 Months Ended
Sep. 30, 2019
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   

Quarter Ended

 
   

September 30,

 
   

2019

   

2018

 

Net sales:

               

Protein Sciences

  $ 140,995     $ 126,391  

Diagnostics and Genomics

    42,552       36,747  

Intersegment

    (304

)

    (168

)

Consolidated net sales

  $ 183,243     $ 162,970  

Operating income:

               

Protein Sciences

  $ 59,538     $ 54,614  

Diagnostics and Genomics

    900       2,536  

Segment operating income

    60,438       57,150  

Costs recognized on sale of acquired inventory

    -

 

    (935

)

Amortization of acquisition related intangible assets

    (14,901

)

    (14,276

)

Acquisition related expenses

    (1,310

)

    (2,631

)

Stock-based compensation, inclusive of employer taxes

    (8,800

)

    (11,565

)

Corporate general, selling, and administrative expenses

    (2,100

)

    (1,980

)

Consolidated operating income

  $ 33,327     $ 25,763